Velcade Sales Data

Last updated: February 2014 (updated quarterly).
The following data shows Velcade U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q2 2012 74 (11) 8.04% 8.90%
Q1 2012 85 (4) 4.42% 2.82%
Q4 2011 89 5.82% 4.41%
Q3 2011 89 (5) 2.42% 1.49%
Q2 2011 94 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
January 27, 2010Velcade (bortezomib): Starting Dose Adjustments-Patients with moderate/severe Hepatic Impairment Should be Treated with Reduced Starting Doses, Closely Monitored
August 27, 2008Combination Therapy Helps to Combat Myeloma
Hide
(web1)